Palisade Bio, Inc. (PALI)

Palisade Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	125.17	133.39	9.82	12.43	12.38	10.5
Cash & Short-Term Investments	125.17	133.39	9.82	12.43	12.38	10.5
Cash Growth	2205.62%	1258.16%	-21.00%	0.40%	17.99%	1339.64%
Accounts Receivable	0.5	-	-	-	-	-
Other Receivables	0	0.26	0.02	0.15	1.44	0.15
Receivables	0.5	0.26	0.02	0.15	1.44	0.15
Prepaid Expenses	1.52	0.57	0.57	0.64	0.8	0.86
Other Current Assets	0.07	-	0.08	0.11	0.11	-
Total Current Assets	127.26	134.22	10.49	13.33	14.73	11.51
Property, Plant & Equipment	-	-	0.09	0.21	0.31	0.11
Other Long-Term Assets	0.06	0.12	0.3	0.52	0.72	0.89
Total Assets	127.32	134.34	10.88	14.05	15.76	12.51

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.84	0.77	1.11	0.7	1.76	1.32
Accrued Expenses	3.41	3.49	1.96	1.61	1.06	0.97
Current Portion of Long-Term Debt	-	0.07	0.08	0.16	0.09	0.09
Current Portion of Leases	-	-	0.09	0.12	0.11	0.11
Other Current Liabilities	-	0.31	-	-	-	-
Total Current Liabilities	5.25	4.64	3.24	2.59	3.01	2.5
Long-Term Leases	-	-	-	0.09	0.21	-
Other Long-Term Liabilities	0.32	0.33	0.15	0.06	0.06	2.65
Total Liabilities	5.57	4.96	3.39	2.74	3.28	5.15

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.74	1.59	0.03	0.01	0.03	0
Additional Paid-In Capital	292.91	280.51	143.41	132.81	121.64	102
Retained Earnings	-172.9	-152.73	-135.94	-121.51	-109.19	-94.64
Total Common Equity	121.75	129.38	7.49	11.31	12.48	7.36
Shareholders' Equity	121.75	129.38	7.49	11.31	12.48	7.37
Total Liabilities & Equity	127.32	134.34	10.88	14.05	15.76	12.51

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	0.07	0.17	0.37	0.4	0.2
Net Cash (Debt)	125.17	133.31	9.65	12.06	11.98	10.3
Net Cash Growth	2358.69%	1281.21%	-19.99%	0.70%	16.35%	-
Net Cash Per Share	0.79	2.39	6.81	26.45	204.12	826.06
Filing Date Shares Outstanding	174.27	165.88	4.4	0.85	0.3	0.02
Total Common Shares Outstanding	173.6	159.44	2.77	0.62	0.2	0.02
Working Capital	122.01	129.59	7.26	10.74	11.72	9.01
Book Value Per Share	0.70	0.81	2.71	18.30	63.57	387.81
Tangible Book Value	121.75	129.38	7.49	11.31	12.48	7.36
Tangible Book Value Per Share	0.70	0.81	2.71	18.30	63.57	387.81

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error